A new class of weight loss drugs known as GLP-1s, like Wegovy and Zepbound, helped grow the weight loss industry to nearly $90 billion last year. Now, weight loss companies, apps and fitness companies are adapting their to programs include the drugs, as well. Also, allegations of serious fraud threaten a big U.S.-U.K. soccer deal, and China’s latest trade data showed a return to growth in April.
Support our nonprofit newsroom today and pick up a fun thank-you gift like our new Shrinkflation mini tote bag or the fan favorite KaiPA pint glass!
Brokerages need to pick up the pace
U.S. child care is expensive — and not working for most families
Can a huge mining industry merger make it to the finish line?
Oil, gas and hurricane season don’t mix
The state of Palestine’s economy
David Beckham scores Euros deal with AliExpress
Tensions between airlines and regulators just in time for Memorial Day travel
When crypto enters campaign finance
Ex-boss appears at inquiry over UK’s “biggest miscarriage of justice”
Will the Ticketmaster antitrust lawsuit make it easier for people to get tickets?
A major step toward paying college athletes
Google’s laying a subsea fiber-optic cable connecting Africa and Australia
Unfavorable views of a (generally) favorable economy
Meet the passive investing doomsayers
Economy takes center stage ahead of U.K. election
Texas’ tech resilience
Inflation is getting better. That doesn’t mean it’s good.
Cuba’s ongoing economic crisis
What two companies can tell us about two corners of the economy
In Houston, storm damage recovery and insurance hurdles
Create your
podcast in
minutes
It is Free
The Commercial Edge: Unleash the Power of People
The emPOWERed Half Hour
Marketplace
On the Media
Planet Money
A Prairie Home Companion: News from Lake Wobegon
In The Dark